Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aptose Bioscns (APTO)

Aptose Bioscns (APTO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aptose Bioscns 12770 HIGH BLUFF DRIVE SUITE 120 SAN DIEGO CA 92130 USA

P: 858-926-2730

Description:

Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid leukemia, high-risk myelodysplastic syndromes and other hematologic malignancies. Its lead program APTO-253 has completed a Phase 1 study in patients with solid tumors. Aptose Biosciences Inc., formerly known as Lorus Therapeutics Inc., is headquartered in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 442,308
Shares Outstanding, K 76,260
Annual Sales, $ 0 K
Annual Net Income, $ -26,280 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,710 K
60-Month Beta 1.77
% of Insider Shareholders 7.34%
% of Institutional Shareholders 40.26%
Float, K 70,663
% Float 92.66%

Growth:

1-Year Return 212.37%
3-Year Return 480.00%
5-Year Return -8.37%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 72.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/05/20
Earnings Per Share ttm -0.52
EPS Growth vs. Prev Qtr -8.33%
EPS Growth vs. Prev Year 23.53%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-12 on 10/07/14

APTO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -2.93
Price/Earnings to Growth N/A
Return-on-Equity % -61.63%
Return-on-Assets % -55.07%
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.66
Book Value/Share 1.23
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar